Neuroblastoma
(asked on 4th July 2016) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, whether new treatments for high-risk neuroblastoma are planned for availability on the NHS.
This question was answered on 12th July 2016
Immunotherapy to treat cancer is an emergent area of clinical practice and, at this stage, there are only a few treatments that have been approved by the National Institute for Health and Care Excellence (NICE) that are commissioned by NHS England. There are currently two new immunotherapies for neuroblastoma in particular which are currently being considered by NICE - dinutuximab and APN311. At present both are only available via clinical trials in the United Kingdom.